Table 2.
Summary of pharmacokinetic parameters (mean ± SD) for lasofoxifene alone or when coadministered with ketoconazole, fluconazole (Study 1) or alone or with paroxetine (Study 2)
Study 1 | Study 2 | ||||
---|---|---|---|---|---|
Parameter | Lasofoxifene alone | Lasofoxifene + ketoconazole | Lasofoxifene + fluconazole | Lasofoxifene alone | Lasofoxifene + paroxetine |
N | 15 | 15 | 15 | 10 | 10 |
Tmax, h | 15.4 ± 7.4 | 9.6 ± 4.5 | 21.3 ± 12.4 | 13.0 ± 6.0 | 11.8 ± 6.6 |
Cmax, ng ml−1 | 0.218 ± 0.033 | 0.249 ± 0.074 | 0.200 ± 0.037 | 0.203 ± 0.050 | 0.243 ± 0.083 |
AUC0–∞, ng h ml−1 | 52.7 ± 9.5 | 63.6 ± 14.0 | 55.3 ± 12.7 | 41.4 ± 4.5 | 56.4 ± 10.2 |
t1/2, h | 196 ± 45.3 | 190 ± 40.0 | 204 ± 30.6 | 168 ± 31.7 | 202 ± 37.2 |
Cmax, Maximum plasma concentration; AUC0–∞, area under plasma concentration–time profile from time zero extrapolated to infinite time; Tmax, time to reach Cmax; t1/2, terminal half-life.